Xenon, Xe-133 (MALLINCKRODT NUCLEAR MEDICINE LLC)


Welcome to the PulseAid listing for the Xenon, Xe-133 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This Inhalation Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MALLINCKRODT NUCLEAR MEDICINE LLC
NON-PROPRIETARY NAME: Xenon
SUBSTANCE NAME: XENON XE-133
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Inhalation Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: GAS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-03-30
END MARKETING DATE: 0000-00-00


Xenon, Xe-133 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXenon, Xe-133 from MALLINCKRODT NUCLEAR MEDICINE LLC
LABELER NAME: MALLINCKRODT NUCLEAR MEDICINE LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mCi/mL)
START MARKETING DATE: 2016-03-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69945-097_a2947596-d8a8-43ac-84ed-e2ec339e3b59
PRODUCT NDC: 69945-097
APPLICATION NUMBER: NDA018327

Other XENON XE-133 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lantheus Medical Imaging, Inc.Xenon
MALLINCKRODT NUCLEAR MEDICINE LLCXenon, Xe-133